Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-03-12
1987-09-08
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514342, 546256, 546277, A61K 3144, A61K 3141, C07D41712, C07D41714
Patent
active
046924566
ABSTRACT:
New 3,4-diamino-1,2,5-thiadiazole oxide derivatives which are histamine H.sub.1 -antagonists. A specific compound of this invention is 3-[3-(N-propyl-N-2-pyridylamino)-propylamino]-4-(4-pyridylmethyl)amino-1,2 ,5-thiadiazole-1-oxide.
REFERENCES:
patent: 4374248 (1983-02-01), Crenshaw et al.
patent: 4394508 (1983-07-01), Crenshaw et al.
patent: 4532246 (1985-07-01), Ife
Briscoe Kurt G.
Hall Linda E.
Jiles Henry R.
Lourie Alan D.
Smith Kline & French Laboratories Limited
LandOfFree
3-Pyridylaminoalkyleneamino-4-amino-1,2,5-thiadiazole-1-oxides, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-Pyridylaminoalkyleneamino-4-amino-1,2,5-thiadiazole-1-oxides, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Pyridylaminoalkyleneamino-4-amino-1,2,5-thiadiazole-1-oxides, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2158492